2,963 results on '"Furue, Masutaka"'
Search Results
2. Biomarkers and patient-related factors associated with clinical outcomes in dupilumab-treated atopic dermatitis
3. An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study
4. The HOME Core outcome set for clinical trials of atopic dermatitis
5. Targeted inhibition of EPAS1-driven IL-31 production by a small-molecule compound
6. Cancer- and noncancer-specific cumulative incidence of death after exposure to polychlorinated biphenyls and dioxins: A competing risk analysis among Yusho patients
7. Effect of Genetic Polymorphisms of Human SLC22A3 in the 5’-flanking Region on OCT3 Expression and Sebum Levels in Human Skin
8. IL-24: A new player in the pathogenesis of pro-inflammatory and allergic skin diseases
9. Implications of IL-13Rα2 in atopic skin inflammation
10. Insight into innate immune response in “Yusho”: The impact of natural killer cell and regulatory T cell on inflammatory prone diathesis of Yusho patients
11. Measuring atopic eczema symptoms in clinical practice: The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiative
12. DNA repair ability in a patient with voriconazole-related squamous cell carcinoma that required differential diagnosis from xeroderma pigmentosum
13. Six Amino Acids among Natural Moisturizing Factors Responsible for Skin Hydration: Improvement and Anti-Aging of Skin by <i>Galactomyces</i> Ferment Filtrate-Pitera<sup>TM</sup> Containing Skin Moisturizer
14. Revival of AHR Agonist for the Treatment of Atopic Dermatitis: Tapinarof
15. Transient improvement of urticaria induces poor adherence as assessed by Morisky Medication Adherence Scale‐8
16. Characterization of socioeconomic status of Japanese patients with atopic dermatitis showing poor medical adherence and reasons for drug discontinuation
17. Poor adherence to medication as assessed by the Morisky Medication Adherence Scale‐8 and low satisfaction with treatment in 237 psoriasis patients
18. Antioxidant cinnamaldehyde attenuates UVB-induced photoaging
19. Potential role of PM2.5 in melanogenesis
20. Influence of dioxin-related compounds on physical function in Yusho incident victims
21. Serum squamous cell carcinoma antigen (SCCA)-2 correlates with clinical severity of pediatric atopic dermatitis in Ishigaki cohort
22. Navigating the landscape of core outcome set development in dermatology
23. Cyto/chemokine profile of in vitro scratched keratinocyte model: Implications of significant upregulation of CCL20, CXCL8 and IL36G in Koebner phenomenon
24. Neural peptidase endothelin-converting enzyme 1 regulates endothelin 1–induced pruritus
25. Exploring patient background and biomarkers associated with the development of dupilumab-associated conjunctivitis and blepharitis
26. Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis – Authors' reply
27. Nocturnal Scratching and Quality of Sleep in Children with Atopic Dermatitis
28. Glucagon-like peptide-1 analogue liraglutide facilitates wound healing by activating PI3K/Akt pathway in keratinocytes
29. Differential efficacy of biologic treatments targeting the TNF-α/IL-23/IL-17 axis in psoriasis and psoriatic arthritis
30. Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study
31. Sleep disorders among Yusho patients highly intoxicated with dioxin-related compounds: A 140-case series
32. Hierarchical control of interleukin 13 (IL-13) signals in lung fibroblasts by STAT6 and SOX11
33. Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine
34. Tryptophan photo-product FICZ upregulates AHR/MEK/ERK-mediated MMP1 expression: Implications in anti-fibrotic phototherapy
35. Protective role of 6-formylindolo[3,2-b]carbazole (FICZ), an endogenous ligand for arylhydrocarbon receptor, in chronic mite-induced dermatitis
36. The role of the OVOL1–OVOL2 axis in normal and diseased human skin
37. Evaluation of mapping biopsies for extramammary Paget disease: A retrospective study
38. Protective role of peroxisome proliferator-activated receptor α agonists in skin barrier and inflammation
39. An endogenous tryptophan photo-product, FICZ, is potentially involved in photo-aging by reducing TGF-β-regulated collagen homeostasis
40. Clinicopathological review of solitary fibrous tumors: dedifferentiation is a major cause of patient death
41. Atopic Dermatitis and Type 2 Immune Deviation
42. Potential Role of Endothelin-1 in Atopic Dermatitis
43. BRAF Heterogeneity in Melanoma
44. Exploring patient background and biomarkers associated with the development of dupilumab-associated conjunctivitis and blepharitis
45. The ability of biomarkers to assess the severity of atopic dermatitis
46. A novel fusion gene CRTC3-MAML2 in hidradenoma: histopathological significance
47. 6-Formylindolo[3,2-b]Carbazole Accelerates Skin Wound Healing via Activation of ERK, but Not Aryl Hydrocarbon Receptor
48. Alteration of PDGFRβ-Akt-mTOR pathway signaling in fibrosarcomatous transformation of dermatofibrosarcoma protuberans
49. The first nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan
50. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.